The effect of soy protein isolate on bone metabolism

Menopause

Volumn 11, Issue 3, 2004, Pages 290-298

  Gallagher, J Christopher ^a   Satpathy, Ruby ^a   Rafferty, Karen ^a   Haynatzka, Vera ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Apoproteins; Bone mineral density; Cholesterol; Isoflavones; Postmenopausal women; Soy

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; DAIDZEIN; EQUOL; GENISTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN; TRIACYLGLYCEROL; APOPROTEIN; OSTEOCALCIN; PLANT EXTRACT;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FEMUR NECK; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID METABOLISM; NORMAL HUMAN; OSTEOLYSIS; PILOT STUDY; POSTMENOPAUSE; PROTEIN ISOLATION; RANDOMIZED CONTROLLED TRIAL; SPINE; BLOOD; DIET SUPPLEMENTATION; MIDDLE AGED; PHYTOTHERAPY; POSTMENOPAUSE OSTEOPOROSIS; TREATMENT OUTCOME;

ADULT; APOPROTEINS; BONE DENSITY; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOFLAVONES; LIPIDS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOTHERAPY; PILOT PROJECTS; PLANT EXTRACTS; SOYBEAN PROTEINS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 4043102051     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000097845.95550.71     Document Type: Article

References (36)

1. Ho SC, Chan SG, Yi Q, Wong E, Leung PC. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 2001;16:1363-1369.
2. Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 2001;97:109-115.
3. Greendale GA, FitzGerald G, Huang MH, et al. Dietary soy Isoflavones and bone mineral density: results from the study of women's health across the nation. Am J Epidemiol 2002;155:746-754.
4. Anderson JJ, Ambrose WW. Orally dosed genistein from soy and prevention of calcaneous bone loss in two ovariectomized rat models. J Nutr 1995;125:799S.
5. Arjmandi BH, Getlinger MJ, Goyal NV, et al. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 1998;68:1358S-1363S.
6. Fanti O, Faugere MC, Gang Z, Schmidt J, Cohen D, Malluche HH. Systemic administration of genistein partially prevents bone loss in ovariectomized rats in a non estrogen-like mechanism. Am J Clin Nutr 1998;68:1517S.
7. Picherit C, Coxam V, Bennetau-Pelissero C, et al. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 2000;130:1675-1681.
8. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(Suppl 6):1375S-1379S.
9. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000;72:844-852.
10. Rapuri PB, Gallagher JC, Haynatzka V. Protein Intake- Effect on Bone Mineral Density and the Rate of Bone Loss in elderly. Women Am J Clin Nutr 2003;77:1517-1525.
11. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263.
12. Chiechi LM, Secreto G, D'Amore M, et al. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas 2002;42:295-300.
13. Hsu CS, Shen WW, Hsueh YM, Yeh SL. Soy Isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med 2001;46:221-226.
14. Dalais FS, Rice GE, Wahlqvist ML, et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998;1:124-129.
15. Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 2001;285:1482-1488.
16. Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME, Arjmandi BH. Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism. J Nutr 2002;132:2605-2608
17. Uesugi T, Fukui Y, Yamori Y. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. Am Coll Nutr 2002;21:97-102.
18. Arjmandi BH, Khalil DA, Smith BJ, et al. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 2003;88:1048-1054.
19. Williams JP, Jordan SE, Banes S, Blair HC. Tyrosine kinase inhibitor effects on avian osteoclastic acid transport. Am J Clin Nutr 1998;68(Suppl 6):1369S-1374S.
20. Yamaguchi M, Sugimoto E. Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: activation of aminoacyl-t-RNA synthetase. Mol Cell Biochem 2000;214:97-102.
21. Viereck V, Grudker C, Blaschke S, et al. Phytoestrogen genistein stimulates the production of osteoprotogerin by human trabecular osteoblasts. J Cell Biochem 2002;84:725-735.
22. Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996;126:161-167.
23. Draper CR, Edel MJ, Dick IM, et al. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J Nutr 1997;127:1795-1799
24. Kritz-Silverstein D, Goodman-Gruen DL. Usual dietary Isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women. J Womens Health Gend Med 2002;11:69-78.
25. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women. Osteoporos Int 2002;13:200-204.
26. Setchell KD, Faughnam MS, Avades T, et al. Comparing the pharmacokinetics of daidzein and genistein with the use of 13 C-labeled tracers in premenopausal women. Am J Clin Nutr 2003;77:411-419.
27. Setchell KDR, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol: a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132:3577-3584.
28. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 1998;217:335-339.
29. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy Isoflavones and lignans: influence of habitual diet on equol production by the gut flora. Nutr Cancer 2000;36:27-32.
30. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-282.
31. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999;6:7-13.
32. Dewell A, Hollenbeck CB, Bruce B. The effects of soy-derived phytoestrogension serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J Clin Endocrinol Metab 2002;87:118-121.
33. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001;86:353-360.
34. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1997;17:3392-3398.
35. Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Croft KD. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr 1998;128:728-32.
36. Simons LA, von-Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial funcion in healthy, postmenopausal women. Am J Cardiol 2000;85:1297-1301.